Cite
HARVARD Citation
Wang, X. et al. (2019). Differential clinical significance of pre-, interim-, and post-treatment plasma Epstein–Barr virus DNA load in NK/T-cell lymphoma treated with P-GEMOX protocol. Leukemia & lymphoma. 60 (8), pp. 1917-1925. [Online].